Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aspira Pathlab & Diagnostics Ltd

₹ 64.7 1.95%
29 Apr 4:01 p.m.
aspiradiagnostics.com BSE: 540788
About

Incorporated in 1973, Aspira Pathlab & Diagnostics Ltd is in the business of pathology and related healthcare services[1]

Key Points

Business Overview:[1]
Company is in the business of running, owning, managing and administering Diagnostics Centers in Mumbai.

Website BSE
  • Market Cap ₹ 66.6 Cr.
  • Current Price ₹ 64.7
  • High / Low ₹ 81.0 / 49.0
  • Stock P/E 27.8
  • Book Value ₹ 7.02
  • Dividend Yield 0.00 %
  • ROCE 17.0 %
  • ROE 33.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Debtor days have improved from 50.5 to 39.0 days.
  • Company's working capital requirements have reduced from 19.6 days to 14.1 days

Cons

  • Stock is trading at 9.11 times its book value
  • Promoter holding is low: 18.4%
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
2.60 3.82 4.64 6.18 5.41 5.78 5.25
3.02 4.03 4.38 4.91 4.81 4.86 4.57
Operating Profit -0.42 -0.21 0.26 1.27 0.60 0.92 0.68
OPM % -16.15% -5.50% 5.60% 20.55% 11.09% 15.92% 12.95%
0.10 0.08 0.16 0.08 0.09 0.13 0.11
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.39 0.38 0.38 0.36 0.39 0.37 0.37
Profit before tax -0.71 -0.51 0.04 0.99 0.30 0.68 0.42
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-0.72 -0.50 0.05 0.99 0.31 0.68 0.42
EPS in Rs -0.70 -0.49 0.05 0.96 0.30 0.66 0.41
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 TTM
13.20 22.00 22.62
14.38 18.49 19.15
Operating Profit -1.18 3.51 3.47
OPM % -8.94% 15.95% 15.34%
0.42 0.36 0.41
Interest 0.37 0.35 0.00
Depreciation 1.54 1.49 1.49
Profit before tax -2.67 2.03 2.39
Tax % 0.00% 0.00%
-2.67 2.02 2.40
EPS in Rs -2.59 1.96 2.33
Dividend Payout % 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 67%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 177%
Stock Price CAGR
10 Years: %
5 Years: 16%
3 Years: 26%
1 Year: -2%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 33%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
Equity Capital 10.29 10.29
Reserves -5.08 -3.06
7.71 8.13
1.79 2.11
Total Liabilities 14.71 17.47
6.79 6.53
CWIP 0.00 0.00
Investments 0.00 0.08
7.92 10.86
Total Assets 14.71 17.47

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
1.05 1.83
0.14 0.12
-0.95 -0.99
Net Cash Flow 0.24 0.95
Free Cash Flow 0.79 1.66
CFO/OP -89% 52%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
Debtor Days 61.94 38.99
Inventory Days 62.69 50.31
Days Payable 101.70 73.00
Cash Conversion Cycle 22.93 16.30
Working Capital Days 25.16 14.10
ROCE % 17.04%

Insights

In beta
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Trade Receivables Turnover Ratio
Ratio ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Total Employees
Count ・Standalone data
B2B Revenue Contribution
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
19.37% 18.90% 18.90% 18.72% 18.72% 18.55% 18.55% 18.39% 18.39% 18.39% 18.39% 18.39%
80.64% 81.10% 81.10% 81.29% 81.28% 81.46% 81.46% 81.62% 81.62% 81.61% 81.61% 81.61%
No. of Shareholders 1,3711,4061,3511,5121,6951,7061,5931,7411,7701,7551,7841,769

Documents

Announcements

Annual reports